<code id='B402123E6B'></code><style id='B402123E6B'></style>
    • <acronym id='B402123E6B'></acronym>
      <center id='B402123E6B'><center id='B402123E6B'><tfoot id='B402123E6B'></tfoot></center><abbr id='B402123E6B'><dir id='B402123E6B'><tfoot id='B402123E6B'></tfoot><noframes id='B402123E6B'>

    • <optgroup id='B402123E6B'><strike id='B402123E6B'><sup id='B402123E6B'></sup></strike><code id='B402123E6B'></code></optgroup>
        1. <b id='B402123E6B'><label id='B402123E6B'><select id='B402123E6B'><dt id='B402123E6B'><span id='B402123E6B'></span></dt></select></label></b><u id='B402123E6B'></u>
          <i id='B402123E6B'><strike id='B402123E6B'><tt id='B402123E6B'><pre id='B402123E6B'></pre></tt></strike></i>

          entertainment

          entertainment

          author:comprehensive    Page View:9
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          FDA seeking to stop procedures at two unregulated stem cell clinics
          FDA seeking to stop procedures at two unregulated stem cell clinics

          StemcellsSpencerPlatt/GettyImagesFederalofficialsmovedonWednesdaytostoptwoclinicsfromcontinuingtooff

          read more
          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more

          Robert Kennedy Jr.'s presidential campaign attracts GOP

          2:45DemocraticpresidentialcandidateRobertF.KennedyJr.deliversaforeignpolicyspeechatSt.AnselmCollegei